Powder: -20°C for 3 years | In solvent: -80°C for 1 year
PMEDAP is a potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality and an inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP also has anti-murine cytomegalovirus (MCMV) activity.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 56.00 | |
2 mg | In stock | $ 79.00 | |
5 mg | In stock | $ 122.00 | |
10 mg | In stock | $ 197.00 | |
25 mg | In stock | $ 455.00 | |
50 mg | In stock | $ 672.00 | |
100 mg | In stock | $ 956.00 | |
500 mg | In stock | $ 1,920.00 |
Description | PMEDAP is a potent inhibitor of Moloney murine sarcoma virus (MSV)-induced tumor formation and associated mortality and an inhibitor of human immunodeficiency virus (HIV) replication. PMEDAP also has anti-murine cytomegalovirus (MCMV) activity. |
In vivo | In Three-week-old male NMRI mice inoculated with MSV, PMEDAP (0.25-5 mg/kg; IP; daily;) effected a significant delay in tumor appearance and an enhancement of the survival rate of tumor-bearing mice. PMEDAP also suppressed tumor formation and mortality in a dose-dependent manner[2]. |
Molecular Weight | 288.2 |
Formula | C8H13N6O4P |
CAS No. | 113852-41-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
0.1 M NaOH: 14.29 mg/mL (49.58 mM), when pH is adjusted to 12 with NaOH. Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
PMEDAP 113852-41-8 Microbiology/Virology Others Proteases/Proteasome HIV Protease sarcoma replication CMV Inhibitor HIV inhibit mice Human immunodeficiency virus Cytomegalovirus mortality virus inhibitor